437 related articles for article (PubMed ID: 16378991)
1. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
Zhu Z; Dimitrov AS; Bossart KN; Crameri G; Bishop KA; Choudhry V; Mungall BA; Feng YR; Choudhary A; Zhang MY; Feng Y; Wang LF; Xiao X; Eaton BT; Broder CC; Dimitrov DS
J Virol; 2006 Jan; 80(2):891-9. PubMed ID: 16378991
[TBL] [Abstract][Full Text] [Related]
2. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.
Zhu Z; Bossart KN; Bishop KA; Crameri G; Dimitrov AS; McEachern JA; Feng Y; Middleton D; Wang LF; Broder CC; Dimitrov DS
J Infect Dis; 2008 Mar; 197(6):846-53. PubMed ID: 18271743
[TBL] [Abstract][Full Text] [Related]
3. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.
Bossart KN; Crameri G; Dimitrov AS; Mungall BA; Feng YR; Patch JR; Choudhary A; Wang LF; Eaton BT; Broder CC
J Virol; 2005 Jun; 79(11):6690-702. PubMed ID: 15890907
[TBL] [Abstract][Full Text] [Related]
4. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
Bossart KN; McEachern JA; Hickey AC; Choudhry V; Dimitrov DS; Eaton BT; Wang LF
J Virol Methods; 2007 Jun; 142(1-2):29-40. PubMed ID: 17292974
[TBL] [Abstract][Full Text] [Related]
5. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein.
Dong J; Cross RW; Doyle MP; Kose N; Mousa JJ; Annand EJ; Borisevich V; Agans KN; Sutton R; Nargi R; Majedi M; Fenton KA; Reichard W; Bombardi RG; Geisbert TW; Crowe JE
Cell; 2020 Dec; 183(6):1536-1550.e17. PubMed ID: 33306954
[TBL] [Abstract][Full Text] [Related]
6. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody.
Xu K; Rockx B; Xie Y; DeBuysscher BL; Fusco DL; Zhu Z; Chan YP; Xu Y; Luu T; Cer RZ; Feldmann H; Mokashi V; Dimitrov DS; Bishop-Lilly KA; Broder CC; Nikolov DB
PLoS Pathog; 2013; 9(10):e1003684. PubMed ID: 24130486
[TBL] [Abstract][Full Text] [Related]
8. Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody.
Bae SE; Kim SS; Moon ST; Cho YD; Lee H; Lee JY; Shin HY; Lee HJ; Kim YB
Biochem Biophys Res Commun; 2019 Jun; 513(4):781-786. PubMed ID: 30995971
[TBL] [Abstract][Full Text] [Related]
9. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.
Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC
J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743
[TBL] [Abstract][Full Text] [Related]
10. Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant.
Wang Z; Dang HV; Amaya M; Xu Y; Yin R; Yan L; Hickey AC; Annand EJ; Horsburgh BA; Reid PA; Smith I; Eden JS; Xu K; Broder CC; Veesler D
Proc Natl Acad Sci U S A; 2022 May; 119(22):e2122769119. PubMed ID: 35617431
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses.
Zhu W; Smith G; Pickering B; Banadyga L; Yang M
Viruses; 2024 May; 16(5):. PubMed ID: 38793674
[TBL] [Abstract][Full Text] [Related]
12. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins.
Dang HV; Cross RW; Borisevich V; Bornholdt ZA; West BR; Chan YP; Mire CE; Da Silva SC; Dimitrov AS; Yan L; Amaya M; Navaratnarajah CK; Zeitlin L; Geisbert TW; Broder CC; Veesler D
Nat Struct Mol Biol; 2021 May; 28(5):426-434. PubMed ID: 33927387
[TBL] [Abstract][Full Text] [Related]
13. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.
Bonaparte MI; Dimitrov AS; Bossart KN; Crameri G; Mungall BA; Bishop KA; Choudhry V; Dimitrov DS; Wang LF; Eaton BT; Broder CC
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10652-7. PubMed ID: 15998730
[TBL] [Abstract][Full Text] [Related]
14. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.
Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B
Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514
[TBL] [Abstract][Full Text] [Related]
15. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
16. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
[TBL] [Abstract][Full Text] [Related]
17. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.
Fischer K; Diederich S; Smith G; Reiche S; Pinho Dos Reis V; Stroh E; Groschup MH; Weingartl HM; Balkema-Buschmann A
PLoS One; 2018; 13(4):e0194385. PubMed ID: 29708971
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the binding interface between monoclonal antibody m102.4 and Nipah attachment glycoprotein using structure-guided alanine scanning and computational docking.
Tit-Oon P; Tharakaraman K; Artpradit C; Godavarthi A; Sungkeeree P; Sasisekharan V; Kerdwong J; Miller NL; Mahajan B; Khongmanee A; Ruchirawat M; Sasisekharan R; Fuangthong M
Sci Rep; 2020 Oct; 10(1):18256. PubMed ID: 33106487
[TBL] [Abstract][Full Text] [Related]
19. Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus.
White JR; Boyd V; Crameri GS; Duch CJ; van Laar RK; Wang LF; Eaton BT
J Gen Virol; 2005 Oct; 86(Pt 10):2839-2848. PubMed ID: 16186240
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.
Zhang MY; Xiao X; Sidorov IA; Choudhry V; Cham F; Zhang PF; Bouma P; Zwick M; Choudhary A; Montefiori DC; Broder CC; Burton DR; Quinnan GV; Dimitrov DS
J Virol; 2004 Sep; 78(17):9233-42. PubMed ID: 15308718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
